Across TCGA pan-cancer cohorts, C1DP4 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated C1DP4 data layer.
The strongest signal is observed in cholangiocarcinoma (CHOL), where higher C1DP4 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated C1DP4 expression acts as an unfavorable survival marker, although some lineages such as BRCA and LAML show a favorable association.
CHOL, HNSC, and KICH are the cancer types where C1DP4 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.